HIV immune evasion and escape through T cell virological synapses

HIV通过T细胞病毒学突触逃避免疫

基本信息

项目摘要

Project Summary HIV-1 establishes a chronic infection that the immune system cannot spontaneously clear. The virus has a remarkable capacity to evade immune responses and generates a high sequence diversity that tolerates defective genes. We and others have found that viral dissemination takes place both in vitro and in vivo through cell-cell contacts, called virological synapses (VS), which can help mask immune detection of infected cells, and promote viral quasispecies diversity that enable escape. Our data indicate that HIV Env, the central viral protein involved in VS formation and viral entry, is regulated during the process of cell-to-cell transmission and assumes distinct conformations on the cell surface versus the virus particle. We examine how low abundance, rapid turnover and heterogeneity of processing of Env at the cell surface contributes to diminished antigenicity of infected cells as compared to abundant cell-free virus or shed glycoprotein. The studies proposed here test a model whereby the sequence of Env trafficking--to the cell surface, to the recycling endosome, and then to the virus particle--supports distinct antigenic states along this pathway. In the prior study periods we have learned that during VS formation Env works as a cell adhesion receptor between the infected and uninfected cell, prior to its role as viral membrane fusion protein. HIV exploits cell biology including the polarized receptor recruitment and viral endocytosis into the target cell, to enhance cell-to-cell transmission. The T cell VS is critical for viral spread in cell culture and functions in vivo in lymphoid tissues of humanized mice. Most broadly neutralizing antibodies (bNAbs) are less potent at neutralizing cell-to-cell infection than the same virus in a cell-free form. When tested against transmitted founder clones, bNAbs frequently fail to inhibit 100% of cell-to-cell infection at maximum concentration, i.e. display reduced efficacy. In the continuation of these studies, we will define the cellular mechanisms underlying the reduced potency and efficacy of neutralizing antibodies against the VS. We will also test a model for how the multicopy transmission of HIV through VS contributes to maintaining a diverse swarm of mutated sequences, or quasispecies, that promotes immune escape. We hypothesize that cell-to-cell HIV-1 transmission is a pivotal immune evasion and escape strategy that drives viral persistence.
项目摘要 HIV-1是一种慢性感染,免疫系统不能自发清除。该病毒具有 逃避免疫应答的显著能力,并产生高序列多样性, 缺陷基因我们和其他人已经发现病毒传播在体外和体内都发生 通过细胞间的接触,称为病毒学突触(VS),这可以帮助掩盖感染的免疫检测。 细胞,并促进病毒准种多样性,使逃脱。我们的数据表明,艾滋病毒Env,中央 一种参与VS形成和病毒进入的病毒蛋白,在细胞间传播过程中受到调节 并在细胞表面呈现与病毒颗粒不同的构象。我们检查有多低 Env在细胞表面的丰度、快速周转和加工的异质性有助于减少 与大量的无细胞病毒或脱落糖蛋白相比,感染细胞的抗原性。研究 这里提出的测试模型,其中的序列Env运输-细胞表面,再循环 内体,然后到病毒颗粒--支持沿着这条途径的不同抗原状态。现有 研究期间,我们已经了解到,在VS形成过程中,Env作为细胞粘附受体, 感染和未感染的细胞,在其作为病毒膜融合蛋白的作用之前。艾滋病毒利用细胞生物学 包括极化受体募集和病毒内吞进入靶细胞,以增强细胞间的相互作用。 传输T细胞VS对于细胞培养物中的病毒传播和体内淋巴组织中的功能是关键的。 人源化小鼠。大多数广泛中和抗体(bNAb)在中和细胞间 感染比相同的病毒在无细胞形式。当针对传播的创始人克隆进行测试时,bNAb 在最大浓度下经常不能抑制100%的细胞间感染,即表现出降低的功效。 在这些研究的继续中,我们将确定降低效力的细胞机制 中和抗体对VS的效力。我们还将测试一个模型, 通过VS传播HIV有助于维持突变序列的多样性群体,或 准种,促进免疫逃逸。我们假设细胞间的HIV-1传播是一个关键因素, 驱动病毒持续存在的免疫逃避和逃逸策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BENJAMIN K CHEN其他文献

BENJAMIN K CHEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BENJAMIN K CHEN', 18)}}的其他基金

Quantifying bNAb neutralization of the HIV latent reservoir
定量 HIV 潜伏库的 bNAb 中和作用
  • 批准号:
    10676564
  • 财政年份:
    2023
  • 资助金额:
    $ 61.67万
  • 项目类别:
Faculty Development Core
教师发展核心
  • 批准号:
    10494242
  • 财政年份:
    2021
  • 资助金额:
    $ 61.67万
  • 项目类别:
Faculty Development Core
教师发展核心
  • 批准号:
    10696176
  • 财政年份:
    2021
  • 资助金额:
    $ 61.67万
  • 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
  • 批准号:
    10570277
  • 财政年份:
    2021
  • 资助金额:
    $ 61.67万
  • 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
  • 批准号:
    10721393
  • 财政年份:
    2021
  • 资助金额:
    $ 61.67万
  • 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
  • 批准号:
    10375603
  • 财政年份:
    2021
  • 资助金额:
    $ 61.67万
  • 项目类别:
Faculty Development Core
教师发展核心
  • 批准号:
    10362243
  • 财政年份:
    2021
  • 资助金额:
    $ 61.67万
  • 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
  • 批准号:
    10600389
  • 财政年份:
    2021
  • 资助金额:
    $ 61.67万
  • 项目类别:
Single cell transcriptomics of HIV persistence and latency
HIV持续性和潜伏期的单细胞转录组学
  • 批准号:
    10258566
  • 财政年份:
    2021
  • 资助金额:
    $ 61.67万
  • 项目类别:
HIV immune evasion and escape through T cell virological synapses
HIV通过T细胞病毒学突触逃避免疫
  • 批准号:
    10484093
  • 财政年份:
    2020
  • 资助金额:
    $ 61.67万
  • 项目类别:

相似海外基金

Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
描述 SARS-CoV-2 抗体反应及其与患者因素的关联:参与 GENCOV 研究的参与者的血清学分析
  • 批准号:
    495256
  • 财政年份:
    2023
  • 资助金额:
    $ 61.67万
  • 项目类别:
Understanding the human antibody response to a malaria transmission-blocking vaccine
了解人类抗体对疟疾传播阻断疫苗的反应
  • 批准号:
    MR/X009491/1
  • 财政年份:
    2023
  • 资助金额:
    $ 61.67万
  • 项目类别:
    Research Grant
Probing the role of peptidoglycan modification in the antibody response to Staphylococcus aureus
探讨肽聚糖修饰在金黄色葡萄球菌抗体反应中的作用
  • 批准号:
    10549646
  • 财政年份:
    2023
  • 资助金额:
    $ 61.67万
  • 项目类别:
Identification of the antigenic targets of the clonal antibody response to Clostridioides difficile infection
鉴定针对艰难梭菌感染的克隆抗体反应的抗原靶点
  • 批准号:
    10742376
  • 财政年份:
    2023
  • 资助金额:
    $ 61.67万
  • 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
  • 批准号:
    10688292
  • 财政年份:
    2022
  • 资助金额:
    $ 61.67万
  • 项目类别:
Molecular dissection of IgA antibody response by developing monoclonal IgA antibodies from nasal mucosa of mice
通过从小鼠鼻粘膜中开发单克隆 IgA 抗体对 IgA 抗体反应进行分子剖析
  • 批准号:
    22H02875
  • 财政年份:
    2022
  • 资助金额:
    $ 61.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
  • 批准号:
    10634694
  • 财政年份:
    2022
  • 资助金额:
    $ 61.67万
  • 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
  • 批准号:
    10514498
  • 财政年份:
    2022
  • 资助金额:
    $ 61.67万
  • 项目类别:
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
  • 批准号:
    10527979
  • 财政年份:
    2022
  • 资助金额:
    $ 61.67万
  • 项目类别:
Factors related to antibody response of COVID-19 vaccines: with focusing on metabolomics
与 COVID-19 疫苗抗体反应相关的因素:重点关注代谢组学
  • 批准号:
    22H03334
  • 财政年份:
    2022
  • 资助金额:
    $ 61.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了